Switzerland-based NBE Therapeutics AG, a biopharmaceutical company, announced a $20 million extension of series B funding led by Novo Holdings. Earlier in the series B funding round, the company had received $20 million, bringing the total funding to $40 million. The Swiss startup will use the new funding for the testing of the anti-ROR1 antibody-drug conjugate (ADC) NBE-002 in patients with solid tumors.
Sanford Health, a healthcare delivery system acquired the Evangelical Lutheran Good Samaritan Society, a senior healthcare services provider for an undisclosed amount. Both South Dakota based healthcare providers announced the merge to form a $6 billion company with 47,000 employees nationwide.
To develop small molecules which can target RNA mis-splicing in neurological diseases, Celgene is launching a $60 million collaboration with Skyhawk Therapeutics. Celgene received the option to develop up to five drug molecules for correcting neurological diseases such as Huntington’s disease, amyotrophic lateral sclerosis etc. The $60 million payment includes milestones, license fees and royalties.
The DDF initially aimed to raise £130 million with committed investments from GlaxoSmithKline, Biogen, Eli Lilly, Pfizer and Takeda, Johnson & Johnson, as well as the U.K. government’s Department of Health and the nonprofit Alzheimer’s Research UK.
KT Corporation, the largest leading telephone company on South Korea, showcased a telemedicine system at its launching ceremony of its global pilot project last week, that connects Central Clinical Hospital No.1 of Moscow, with regional hospitals in Tula and Yaroslavl, 200 km and 300 km away for the capital.
German Based Medical Tech Company Siemens Healthineers recently launched “Acuson Sequoia” a new imaging ultrasound system which enables imaging of different sized patients with unchanging clarity. The newly developed devices provide advanced high-powered architecture Deep Abdominal Transducer (DAX) and other improvements to elastography and contrast-enhanced ultrasound. To enable better diagnosis the device can produce penetration of up to 40cm to offer high-resolution imaging.
Johnson & Johnson Innovation in collaboration with New York State and the New York Genome Center launched JLABS in New York Genome Center, New York City. The size of the new facility is 30,000 Sq. ft. The new facility will enable 30 biotech, medical device, pharmaceutical, consumer and health tech companies with 26 resident companies, including the four winners of the JLABS at QuickFire Challenge.
India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
There will be a total of twenty-four education categories/topics, which includes five new topics namely consumerization of health, grand societal challenges, healthy aging and technology, population and public health management as well as supply chain management.
The IPO has provided the biotech major with the financial bandwidth to aggressively pursue its new generation of CAR-T variants on a broader level, with the advancement of several therapies or the start of clinical trials over the next couple of months.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.